Veronique

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Veronique

Property Description
Active ingredient Permethrin
Form Cream or Lotion
Pharmacological class Pyrethroid (Synthetic), Ectoparasiticide
Common use Treatment of parasitic infestations
Origin Synthetic

What Type of Medicine is Veronique and What is its Purpose?

Veronique is a pharmaceutical preparation classified as an ectoparasiticide and a topical anti-infective, intended exclusively for external use against parasitic infestations. Its fundamental purpose is infestation treatment by eliminating external parasites that settle on human skin and hair. Veronique is utilized for resolving infestations, acting as both a scabicide and a pediculicide, thereby addressing conditions like scabies and lice infestations. Permethrin is indicated for the treatment of scabies and lice to achieve parasitic elimination.


Permethrin: Understanding the Active Ingredient and Class

The identity of Veronique is determined by its single active ingredient, Permethrin, an active agent belonging to the pyrethroid class. Permethrin is classified as a synthetic pyrethroid, meaning it is chemically synthesized but structurally related to naturally occurring pyrethrins, which are derived from chrysanthemums. This formulation places the product under the broader pharmacological class of topical anti-infectives. Permethrin functions as a neurotoxin to arthropods, leading to their paralysis and elimination. This chemical action occurs on the nerve cell membranes of insects and mites.


Veronique’s Form and Route of Administration

Veronique is available as a single-ingredient product in various dosage form(s), primarily the cream and lotion formulations, which allow for a controlled application to the affected areas. The drug is strictly limited to the topical route of administration, meaning it must be applied directly to the skin or hair surface. Its formulation typically involves Permethrin suspended in a cream base or a lotion vehicle, ensuring contact time with the infested area necessary for the active ingredient to work. This choice of topical vehicle is designed for local coverage and patient comfort.

Regulatory References

  1. pyrethroid

What side effects are possible with Veronique?

Possible Side Effects and Safety Information

The safety profile of topical permethrin, the active ingredient in Veronique, is characterized primarily by localized and transient adverse reactions, as documented in government regulatory sources.

Common Adverse Reactions

The most frequently reported effects are generally mild and limited to the application site, classified as common in official documents. These include sensations such as pruritus (itching), burning, stinging, and paraesthesia (numbness or tingling of the skin). Other common effects may involve headache and localized erythema (redness) or rash. The sensation of burning or stinging is typically transient and often occurs soon after the cream is applied.

Time-Related Safety Patterns

Official labeling notes that the itching associated with the original infestation may persist for up to four weeks after treatment. This prolonged pruritus is generally considered a reaction to the dead mites under the skin and is not necessarily an indication of treatment failure.

Safety Restrictions and Special Populations

Use of the product is contraindicated in individuals with known hypersensitivity to permethrin, other substances of the pyrethroid group, or related plants such as chrysanthemums. For pediatric patients, safety and effectiveness have been established for use in children two months of age and older; data for infants younger than two months is limited.

The regulatory framework confirms that the most common adverse reactions are cutaneous and neurological in nature, helping to structure the overall safety understanding as one of localized, short-lived irritation rather than systemic risk.

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory information concerning Veronique (Permethrin) overdose is structured around the two primary routes of exposure: topical misuse and accidental oral ingestion. Overuse by topical application is documented to cause localized skin effects, which may include transient erythema, edema, excoriations, or a localized burning sensation.

Accidental Oral Ingestion constitutes the critical overdose scenario. Following this route of exposure, official labeling describes systemic manifestations such as nausea, vomiting, dizziness, and headache. The primary focus of concern is the central nervous system (CNS), where severe manifestations such as fine tremor and, in rare documented cases, convulsions or seizures may occur.

Mandatory Emergency Response

Immediate medical attention is officially required for any accidental oral ingestion. Regulatory instructions mandate that emergency services or a Poison Control Center must be contacted immediately. Management, as defined by regulatory documents, is limited to symptomatic and supportive treatment because no specific antidote is known for Permethrin overdose. Hospital monitoring and continuous observation are officially required, specifically to manage and observe for the development of any CNS or systemic effects. The accidental ingestion risk for pediatric patients is noted in regulatory warnings.

Therapeutic Uses of Veronique

What Veronique Treats: Main Uses and Benefits

Veronique is used in situations involving certain distressing symptoms, generally applied across domains where additional symptomatic support is needed. This therapeutic support is considered relevant for easing symptoms that interfere with daily functioning and those associated with acute or episodic changes.

This class of medication is utilized for easing discomfort related to pain, inflammation, and systemic imbalance like fever. Veronique may be applied in conditions where symptoms escalate temporarily, such as musculoskeletal aches, localized swelling, and general malaise.

It is commonly used when short-term symptomatic assistance is needed to help with symptoms related to heightened physiological activity.

Veronique helps address symptom clusters that may become intense or disruptive, offering symptomatic relief that may help patients manage symptoms. It is applied during phases of increased distress or discomfort, supporting comfort during symptomatic periods.


Quick Fact: Relief for Acute Discomfort

Veronique is commonly used to help with symptomatic manifestations across domains involving heightened physiological activity, such as pain and fever.

Regulatory References

  1. NIH MedlinePlus overview of Analgesics and Fever Reducers

Eligibility and Restrictions for Use

Eligibility for Veronique (Permethrin) Use

Absolute Contraindications

Veronique is contraindicated and must not be used by individuals with a documented hypersensitivity or known allergy to the active substance, permethrin, to any related synthetic pyrethroid compound, or to any non-active ingredients in the cream or lotion formulation.

Age-Related Eligibility

The medicine is not recommended for and must not be used in infants under 2 months of age, as regulatory safety and effectiveness data have not been established for this population. Treatment for children aged 2 months to 23 months is permitted but should only be given under close medical supervision. Use is established and generally approved for adolescents, adults, and older adults.

Conditional Use and Restrictions

For pregnant women, use is conditional and should be decided upon only if the medical need is clear, due to a lack of adequate and well-controlled human studies. For nursing mothers, official labeling suggests considering temporary discontinuation of breastfeeding. The medicine must not be applied to broken skin or mucous membranes to avoid irritation and potential absorption. Regulatory documents do not define specific eligibility restrictions based on renal or hepatic impairment.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official regulatory profile for Veronique (Permethrin) is distinctive due to the medication’s topical route and minimal systemic absorption, which limits the potential for conventional systemic drug interactions.

Interaction Scope

The documented interaction pattern is a pharmacodynamic effect involving other topical agents, rather than a pharmacokinetic interaction that affects drug levels.

Interaction Category Official Regulatory Statement
Documented Pharmacodynamic Interaction Co-administration with topical corticosteroids (used to treat related skin reactions) carries a documented risk of exacerbating the infestation by dampening the host's local immune response.
Timing-Based Interaction Rule Treatment with topical corticosteroids for eczematous-like reactions should be withheld prior to the application of Veronique, as specified in regulatory prescribing information.
Systemic & Substance Interactions No interactions are known with systemic medicinal products, food, alcohol, or herbal products. Official labeling states that due to the low systemic exposure of Permethrin, pharmacokinetic interactions (e.g., involving CYP enzymes or transporters) are not expected or not established.

Interaction Classifications

Interaction Severity Classification: No drug-drug combinations are listed as formally contraindicated. The sole documented interaction is classified as a functional use-with-caution scenario requiring a timing restriction. The restriction ensures the medicine's full efficacy is realized by preventing the functional conflict that may worsen the underlying condition.

Mechanism of Action

How Veronique Works

Veronique exerts its action through engagement with specific biological processes. Its primary effect involves interaction with specific regulatory systems, resulting in modulation of intracellular signaling cascades.

Targeted Modulation of Receptor Systems

Veronique operates by selectively binding to specific receptor systems within defined neural and/or humoral pathways. This binding influences the signal transduction process to modulate activity within systems where specific mediators or transmitters dominate.

Modulation of Pathway Activity

The interaction at the receptor level initiates a mechanistic cascade designed to influence specific signaling sequences associated with heightened physiological responses. This modulation is applied to pathways characterized by excessive activity, contributing to adjustment in activity within the targeted pathways.

Influence on Physiological Regulation

The mechanism involves restricting the resulting activity associated with heightened signaling. The focused interaction with key regulatory systems influences the resulting physiological effects, producing adjustments consistent with the drug’s defined mechanistic profile, thereby affecting systemic physiological regulation.

Dosage and Administration Information

How to Use Veronique

Veronique (Permethrin) is a pharmaceutical preparation used exclusively as a topical treatment, applied externally to the skin or hair according to the specific parasitic condition. The general principle of administration is a single-course application, with the required strength and contact time determined by the treatment area.


Official Administration Protocol

Usage Constraint Application Instruction
Administration Route For external use only on the skin and hair; contact with eyes and mucous membranes must be avoided.
Scabies (5% Cream) A sufficient quantity is applied to cover the entire body surface from the neck down to the soles of the feet. This application is typically left on for 8 to 14 hours.
Lice (1% Product) A sufficient quantity is applied to saturate the hair and scalp, typically for 10 minutes, before being rinsed off.
Frequency The standard is a single application. Re-treatment is only considered if persistent live mites or lice are observed 7 to 14 days after the initial course.

Procedural and Population-Specific Rules

Application should occur on clean, dry, cool skin (for scabies) or clean, towel-dried hair (for lice) to ensure optimal coverage. After the required contact time has elapsed, the product must be thoroughly rinsed off with water.

The product is generally indicated for use in patients 2 months of age and older. For treating older adults with scabies, the application may be modified to include the head, neck, scalp, and ears if these areas are infested, which is not the standard procedure for younger adults.

Recent Clinical Evidence

Veronique: Overview of Clinical Studies

Evidence for Use in Treating Scabies Infestations

Systematic reviews and high-level analyses, which pool data from randomized controlled trials (RCTs), have been conducted for the clinical situation of scabies infestation. The research was studied for use in patient groups with confirmed or suspected mite infestations. Studies explored the observed rates of parasite clearance, alongside recorded changes in the clinical signs of infestation. Outcomes monitored included the absence of the parasite recorded according to the study protocol. The findings describe short-term outcomes measured over defined time intervals following the use of the medicine.


Evidence for Use in Treating Lice Infestations

Similar evidence structures were applied to study research exploring the clinical situation of lice elimination. The research was studied for use in patient groups, including both children and adults. Studies monitored measurements of clinical outcomes, including the presence or absence of lice, eggs, or nits. Data describe patterns related to the monitored rate of parasite absence, which was the central focus of these trials. The evidence assists in contextualizing observed symptom patterns and describes the data measured during the study periods.


Long-Term Follow-Up and Research Gaps

Research has primarily focused on immediate or short-term outcomes observed in the weeks following application. The follow-up durations were often limited to the time needed to confirm the initial absence of the parasite, meaning long-term effects are not fully established. Data for certain groups remain insufficient; for instance, specific findings for infants under two months are not well characterized. Additionally, evidence quality varies across studies, and uncertainty remains regarding the precise time required for associated symptoms, such as persistent itching, to fully resolve.

Frequently Asked Questions (FAQ)

Common questions about Veronique (FAQ)


Q: How quickly does Veronique start working?

Veronique’s active ingredient works by affecting the nerve cells of parasites, which begins the process of paralysis upon contact. Official regulatory information emphasizes that the product must remain on the treatment area for the full contact time—for example, 10 minutes for lice or 8 to 14 hours for scabies—to achieve the necessary effect for the elimination of the infestation. The full treatment effect is achieved once the specified application time is complete.


Q: How long do the effects of Veronique last?

The product is designed for a single application to treat the infestation. Official guidelines suggest re-treatment only if live parasites are found 7 to 14 days after the initial application. This re-treatment interval reflects the expected duration of the residual effect needed to allow for the observation of the full treatment response.


Q: Is Veronique considered a 'strong' medicine?

Veronique's active ingredient is classified as a pyrethroid neurotoxin, indicating its mechanism of action against arthropods. According to official documents and systematic reviews, the medicine demonstrates high efficacy for the elimination of scabies and lice infestations.


Q: Does Veronique cause drowsiness or fatigue?

The most commonly reported side effects are localized skin reactions like burning, stinging, or itching. While some systemic symptoms such as headache have been reported post-marketing, official prescribing information does not typically list drowsiness or fatigue among the most common adverse reactions.


Q: Are there any serious side effects associated with Veronique?

The safety profile is mainly characterized by temporary and localized reactions at the application site. The primary serious concern described in official documents is a severe allergic reaction (hypersensitivity) to the active or inactive ingredients, which is a contraindication for use. Regulatory authorities have also noted rare, unconfirmed reports of more systemic events, such as seizures, occurring post-marketing.


Q: Can Veronique affect my sleep pattern?

Official product labels generally focus on localized symptoms like skin irritation. Disturbances to sleep patterns or insomnia are not commonly listed among the adverse effects described in the official prescribing information for this topical medicine.


Q: Is it normal to feel [mild side effect, e.g., slightly dizzy] after starting Veronique?

It is common to experience temporary and localized effects at the application site, such as tingling, stinging, or itching. Official regulatory documentation also notes that symptoms like headache and mild dizziness have been reported among the adverse events.


Q: Is it safe to drive or operate machinery while on Veronique?

Official regulatory labels state that, due to the minimal systemic absorption of the medicine when used as directed, no effect on the ability to drive or operate machinery is expected.


Q: What happens if I miss a use of Veronique?

Veronique is a single-application treatment, meaning the concept of a routine 'missed dose' does not typically apply. Official regulatory documents describe that the treatment is intended to remain on the body for the full required contact time. If live parasites are observed after a minimum of 7 to 14 days, re-treatment may be considered.


Q: Does Veronique have a generic version available?

Yes, the active ingredient in Veronique is permethrin. Official regulatory databases confirm that permethrin topical creams and rinses are commonly available in generic form, as Veronique is a brand name for this medication.


Q: Is Veronique a common prescription, or is it a newer drug?

The active ingredient, permethrin, is not a newer drug; it is a globally established medication. Major health organizations recognize this ingredient as an established treatment for scabies and lice, confirming its widespread and established status in infestation management.


Q: Does Veronique require any special monitoring or blood tests?

No. Regulatory documents state that routine safety monitoring or blood tests are not required when using this product as directed. This is because the medicine has minimal systemic absorption (less than 2% of the dose applied), meaning very little enters the bloodstream.


Q: Is Veronique known to cause weight gain or loss?

Official regulatory labels do not list significant changes in body weight as a reported side effect. This is consistent with the medicine's low systemic absorption when applied topically, meaning it typically acts locally and is not associated with systemic weight effects.


Q: Does Veronique affect blood pressure?

According to official regulatory labels, significant changes in blood pressure are not listed as a reported side effect. This aligns with the medicine's topical route of administration and minimal systemic absorption.


Q: What organ systems does Veronique affect (e.g., liver, kidneys)?

Official documents describe that the small amount of medication absorbed systemically is rapidly metabolized in the liver into inactive forms. These inactive substances are then excreted primarily in the urine. The low absorption rate suggests minimal impact on these organs when the product is used topically as prescribed.


Q: How is Veronique eliminated from the body?

The small fraction of the medicine that is absorbed into the bloodstream is rapidly broken down (metabolized) by enzymes in the liver. These resulting inactive substances are then eliminated from the body, primarily by being excreted in the urine.


Q: Does Veronique have a specific time of day it should be used?

Regulatory labels do not specify a required time of day for application (e.g., morning versus evening). Because the scabies treatment requires a long contact time, often 8 to 14 hours, official information notes that the application time is often scheduled for the evening to align with this required duration.


Q: Does Veronique cause mood changes or emotional side effects?

Official product information focuses on neurological symptoms like temporary tingling or headache. Mood changes or emotional side effects are not listed among the commonly reported adverse reactions described in official labels for this medication.


Q: Can Veronique affect fertility?

Based on official regulatory documents, non-human animal studies (mice, rats, and rabbits) that tested high oral doses of the active ingredient showed no evidence of impaired fertility. Specific human data on fertility effects are not available.


Q: Is it common to have an upset stomach with Veronique?

The most common adverse reactions reported are those at the application site. While regulatory bodies have noted post-marketing reports of systemic issues, such as nausea or abdominal pain, these are not typically listed among the most common adverse reactions.


Q: Does Veronique contain gluten or lactose?

Official excipient lists for the cream formulation indicate that it does not contain gluten or lactose. Regulatory labels, however, confirm the presence of other excipients, such as cetostearyl alcohol, which may cause localized reactions in sensitive individuals.

How should Veronique be stored and disposed of?

How to Store and Dispose of Veronique

The storage and disposal instructions for Veronique (Permethrin 5% Cream) are strictly defined by regulatory requirements to maintain product stability and ensure environmental safety.

Storage Requirements

Condition Requirement
Temperature Store at a Controlled Room Temperature of 20 C to 25 C (68 F to 77 F), with permitted excursions up to 30 C
Protection Keep away from excessive heat, moisture, and direct light. Do not freeze the product
Container Must be stored in its original container and kept tightly closed when not in use
Child Safety Keep the medicine out of the sight and reach of children

Disposal Requirements

Unused or expired Veronique must be disposed of according to local pharmaceutical waste regulations. The preferred disposal method is utilizing an official drug take-back program. If a take-back program is unavailable, the product may be disposed of in household trash by mixing it with an undesirable substance, such as dirt or used coffee grounds, and placing the mixture in a sealed container.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Veronique found in:

A-Z Index: